These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8182 related articles for article (PubMed ID: 2302652)
1. Progress in the systemic treatment of cancer. Concepts, trials, drugs, and biologics. Carbone PP Cancer; 1990 Feb; 65(3 Suppl):625-33. PubMed ID: 2302652 [TBL] [Abstract][Full Text] [Related]
2. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Crawford S Front Pharmacol; 2013; 4():68. PubMed ID: 23805101 [TBL] [Abstract][Full Text] [Related]
3. The p97 antigen is mapped to the q24-qter region of chromosome 3; the same region as the transferrin receptor. Seligman PA; Butler CD; Massey EJ; Kaur JA; Brown JP; Plowman GD; Miller Y; Jones C Am J Hum Genet; 1986 Apr; 38(4):540-8. PubMed ID: 3010712 [TBL] [Abstract][Full Text] [Related]
4. Ablation of the brachial plexus. Control of intractable pain, due to a pathological fracture of the humerus. Neill RS Anaesthesia; 1979; 34(10):1024-7. PubMed ID: 539638 [TBL] [Abstract][Full Text] [Related]
5. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity. Slavik M; Blanc O; Davis J Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of melanoma. Nathanson L J Cutan Pathol; 1979 Jun; 6(3):213-26. PubMed ID: 383755 [TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Yokota T; Nishio H; Kubota Y; Mizoguchi M Pigment Cell Res; 1998 Dec; 11(6):355-61. PubMed ID: 9870547 [TBL] [Abstract][Full Text] [Related]
9. Differential response of adherent and unanchored melanoma cells to bromodeoxyuridine evidenced by specific lectin-binding protein changes. Rieber M; Rieber MS; Urbina C; Lira R Int J Cancer; 1989 May; 43(5):841-4. PubMed ID: 2714888 [TBL] [Abstract][Full Text] [Related]
10. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology. Simons JW; Mikhak B Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681 [TBL] [Abstract][Full Text] [Related]
11. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients. Grosser N; Thompson DM Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711 [TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of cancer therapy with recombinant interleukin-2 administered by intravenous bolus injection. Hersh EM; Murray JL; Hong WK; Rosenblum MG; Reuben JM; Weilbaecher R; Sarwal AN; Bradley EC; Konrad M; Arnett FC Biotherapy; 1989; 1(3):215-26. PubMed ID: 2642025 [TBL] [Abstract][Full Text] [Related]
19. Multiple epitope recognition: an approach to improved radioimmunodetection of tumor-associated antigens. Giacomini P; Segatto O; Natali PG Int J Cancer; 1987 Jun; 39(6):729-36. PubMed ID: 2438235 [TBL] [Abstract][Full Text] [Related]